期刊
AUTOIMMUNITY REVIEWS
卷 7, 期 3, 页码 256-261出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.autrev.2007.11.020
关键词
autoimmunity; CD3 zeta; pathogenesis; PP2A; systemic lupus erythematosus; therapy
类别
资金
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049954, R01AI042269] Funding Source: NIH RePORTER
- NIAID NIH HHS [R01 AI049954-04, R01 AI042269, R01 AI049954, R01 AI042269-09] Funding Source: Medline
T cells from patients with systemic lupus erythematosus (SLE) display a number of biochemical abnormalities which include altered expression of key signaling molecules, heightened calcium responses, and skewed expression of transcription factors. These defects are involved in the altered behavior of SLE T cells and are probably central in the disease pathogenesis. The aim of this communication is to review the defects that have been consistently documented in SLE T cells, highlighting molecules and pathways that represent therapeutic targets. (C) 2007 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据